TAMOXIFEN VERSUS HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE AS INITIAL ENDOCRINE THERAPY FOR PATIENTS WITH METASTATIC BREAST-CANCER - A PIEDMONT-ONCOLOGY-ASSOCIATION STUDY

MUSS HB CASE LD ATKINS JN BEARDEN JD COOPER MR CRUZ JM JACKSON DV OROURKE MA PAVY MD POWELL BL RICHARDS F SPURR CL EAGLE K WHITE DR

Hb. Muss et al., TAMOXIFEN VERSUS HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE AS INITIAL ENDOCRINE THERAPY FOR PATIENTS WITH METASTATIC BREAST-CANCER - A PIEDMONT-ONCOLOGY-ASSOCIATION STUDY, Journal of clinical oncology, 12(8), 1994, pp. 1630-1638

33

Oncology

Journal of clinical oncology → ACNP

0732183X

12

8

1994

1630 - 1638

ISI

0732-183X(1994)12:8<1630:TVHOMA>2.0.ZU;2-7